Literature DB >> 22487747

Neurodegenerative disease: Establishing a clinical trial battery for Huntington disease.

Jane S Paulsen, Jeffrey D Long.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22487747      PMCID： PMC4219567          DOI： 10.1038/nrneurol.2012.67

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  4 in total

1.  Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.

Authors:  Sarah J Tabrizi; Ralf Reilmann; Raymund A C Roos; Alexandra Durr; Blair Leavitt; Gail Owen; Rebecca Jones; Hans Johnson; David Craufurd; Stephen L Hicks; Christopher Kennard; Bernhard Landwehrmeyer; Julie C Stout; Beth Borowsky; Rachael I Scahill; Chris Frost; Douglas R Langbehn
Journal:  Lancet Neurol       Date:  2011-12-02       Impact factor: 44.182

Review 2.  Intervention of Proliferation and Differentiation of Endogenous Neural Stem Cells in the Neurodegenerative Process of Huntington's Disease Phenotype.

Authors:  Yvona Mazurová; Ivana Gunčová; Ivan Látr; Emil Rudolf
Journal:  CNS Neurol Disord Drug Targets       Date:  2011-06       Impact factor: 4.388

Review 3.  Cognitive impairment in Huntington disease: diagnosis and treatment.

Authors:  Jane S Paulsen
Journal:  Curr Neurol Neurosci Rep       Date:  2011-10       Impact factor: 5.081

Review 4.  Huntington's disease: from molecular pathogenesis to clinical treatment.

Authors:  Christopher A Ross; Sarah J Tabrizi
Journal:  Lancet Neurol       Date:  2011-01       Impact factor: 44.182
  4 in total
  4 in total

1.  Cognitive decline in prodromal Huntington Disease: implications for clinical trials.

Authors:  Jane S Paulsen; Megan M Smith; Jeffrey D Long
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-08-02       Impact factor: 10.154

Review 2.  A review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases.

Authors:  Jane S Paulsen; Martha Nance; Ji-In Kim; Noelle E Carlozzi; Peter K Panegyres; Cheryl Erwin; Anita Goh; Elizabeth McCusker; Janet K Williams
Journal:  Prog Neurobiol       Date:  2013-09-11       Impact factor: 11.685

3.  Multivariate clustering of progression profiles reveals different depression patterns in prodromal Huntington disease.

Authors:  Ji-in Kim; Jeffrey D Long; James A Mills; Elizabeth McCusker; Jane S Paulsen
Journal:  Neuropsychology       Date:  2015-05-25       Impact factor: 3.295

4.  WHODAS 2.0 in prodromal Huntington disease: measures of functioning in neuropsychiatric disease.

Authors:  Nancy R Downing; Ji-In Kim; Janet K Williams; Jeffrey D Long; James A Mills; Jane S Paulsen
Journal:  Eur J Hum Genet       Date:  2013-12-11       Impact factor: 4.246
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.